Profile picture
, 3 tweets, 3 min read
My Authors
Read all threads
#FactsNotFear

-Strong, pre-existing, long-lasting, cross-protective #TCellImmunity against #SARSCoV2 & strong T-cell immune responses to virus: bode well for long-term immunity via natural herd immunity
-#HCQWorks both as prophylaxis & as outpatient treatment in early #COVID19
2/ Knowledge is Power. Learn about powers of your innate immune system & your adaptive cellular immune system: protect you against #SARSCoV2 & critical to beat #COVID19

#HCQ activates host anti-viral innate immunity

Herd immunity closer than we think d/t strong T-cell immunity
3/ You'll observe a common thread: the same academics, BigPharma, WHO officials, politicians & media who continue unethical anti-HCQ attacks are also the same ones who fail to ever mention innate & T-cell immunity—b/c effectiveness of both against #SARSCoV2 ends the Fear pandemic
Missing some Tweet in this thread? You can try to force a refresh.

Keep Current with Kulvinder Kaur MD

Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

Twitter may remove this content at anytime, convert it as a PDF, save and print for later use!

Try unrolling a thread yourself!

how to unroll video

1) Follow Thread Reader App on Twitter so you can easily mention us!

2) Go to a Twitter thread (series of Tweets by the same owner) and mention us with a keyword "unroll" @threadreaderapp unroll

You can practice here first or read more on our help page!

Related hashtags

#FactsNotFear #TCellImmunity #SARSCoV2 #HCQWorks #COVID19 #HCQ

More from @dockaurG see all

Profile picture
Kulvinder Kaur MD
@dockaurG
Pls read #SARSCoV2 immunology🧵& subthreads for what media & “experts” are not telling you

Facts
-we have some pre-existing cross-protective immunity
-basing herd immunity only on antibodies omits strong Tcell immunity
-vaccine candidates not effective b/c don’t elicit IgA prodn
2/ Last week, researchers in Sweden and Germany also found strong T-cell responses to #SARSCoV2 which bode well for long-term immunity & found pre-existing cross-protective immunity: findings are consistent with the original US Cell study published in May.
3/ We now have three independent #SARSCoV2 studies, from teams of scientists in three different countries, all concluding the same thing:

“#COVID19 Herd Immunity Is Much Closer Than Antibody Tests Suggest”
reason.com/2020/07/01/cov…
Read 13 tweets
Profile picture
Kulvinder Kaur MD
@dockaurG
Thread: Questions we should be asking. Why are so many #SARSCoV2 studies focusing on humoral immunity & neutralizing antibodies when B-cell antibody production is not crucial to overcome #COVID19? It is the strong cytotoxic T-cell responses that bode well for long-term immunity.
2/ Antibody isotope in humoral immunity also matters. #SARSCoV2 antibody studies are only focusing on IgG which provides late #COVID19 protection in the lower airways: the lungs. It is secretory IgA in the nasal mucosa that provides early COVID-19 protection in the upper airways.
3/ Significant lack of discussion of latter: #SARSCoV2 vaccine candidates via intra-muscular injection would NOT confer IgA immunity. Successful #SARSCoV2 containment in upper resp tract requires IgA, not IgG. Leading vaccine candidates against #COVID19 do NOT elicit IgA prod’n.
Read 3 tweets
Profile picture
Kulvinder Kaur MD
@dockaurG
Based on published #HCQ studies & case-controlled clinical trials, HCQ has significant efficacy in early treatment of #COVID19: PRE-exposure prophylaxis & early POST-exposure treatment. Recent NEJM RCT focused on NEITHER of these 2 key groups but rather: POST-exposure prophylaxis
2/ Here’s link to NEJM #HCQ RCT published today on POST-exposure prophylaxis given up to 4d AFTER exposure. Disturbing that science was again politically sensationalized by media before study was even published w/quotes from MD with #Gilead #BigPharma COI
nejm.org/doi/full/10.10…
3/ “The results reported by Boulware et al. are more provocative than definitive, suggesting the potential prevention benefit(s) of #Hydroxychloroquine remain to be determined,” concluded Dr. Myron Cohen MD in NEJM editorial re recent NEJM HCQ #COVID19 RCT
nejm.org/doi/full/10.10…
Read 4 tweets

Embed code for your website

×
Follow Us on Twitter!

Did Thread Reader help you today?

Support us! We are indie developers!

This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3.00/month or $30.00/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!